| Biogenesis of cytosolic ribosomes requires the essential iron–sulphur protein Rli1p and mitochondria G Kispal, K Sipos, H Lange, Z Fekete, T Bedekovics, T Janáky, J Bassler, ... The EMBO journal 24 (3), 589-598, 2005 | 314 | 2005 |
| Functional analyses of placental protein 13/galectin‐13 NG Than, E Pick, S Bellyei, A Szigeti, O Burger, Z Berente, T Janaky, ... European Journal of Biochemistry 271 (6), 1065-1078, 2004 | 223 | 2004 |
| New antagonists of LHRH II. Inhibition and potentiation of LHRH by closely related analogues S Bajusz, VJ Csernus, T Janaky, L Bokser, M Fekete, AV Schally International Journal of Peptide and Protein Research 32 (6), 425-435, 1988 | 175 | 1988 |
| Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease Z Hartai, A Juhász, Á Rimanóczy, T Janáky, T Donkó, L Dux, B Penke, ... Neurochemistry international 50 (2), 308-313, 2007 | 151 | 2007 |
| Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2 A Pal, D Mehn, E Molnar, S Gedey, P Meszaros, T Nagy, H Glavinas, ... Journal of Pharmacology and Experimental Therapeutics 321 (3), 1085-1094, 2007 | 128 | 2007 |
| Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects. S Bajusz, M Kovacs, M Gazdag, L Bokser, T Karashima, VJ Csernus, ... Proceedings of the National Academy of Sciences 85 (5), 1637-1641, 1988 | 124 | 1988 |
| Kynurenine metabolism in multiple sclerosis Z Hartai, P Klivényi, T Janáky, B Penke, L Dux, L Vécsei Acta Neurologica Scandinavica 112 (2), 93-96, 2005 | 122 | 2005 |
| Analogues of luteinizing hormone-releasing hormone containing cytotoxic groups. T Janaky, A Juhasz, S Bajusz, V Csernus, G Srkalovic, L Bokser, ... Proceedings of the National Academy of Sciences 89 (3), 972-976, 1992 | 119 | 1992 |
| Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease Z Hartai, P Klivenyi, T Janaky, B Penke, L Dux, L Vecsei Journal of the neurological sciences 239 (1), 31-35, 2005 | 115 | 2005 |
| Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone. S Bajusz, T Janaky, VJ Csernus, L Bokser, M Fekete, G Srkalovic, ... Proceedings of the National Academy of Sciences 86 (16), 6313-6317, 1989 | 98 | 1989 |
| P-glycoprotein inhibition by membrane cholesterol modulation F Fenyvesi, E Fenyvesi, L Szente, K Goda, Z Bacsó, I Bácskay, J Váradi, ... European journal of pharmaceutical sciences 34 (4-5), 236-242, 2008 | 91 | 2008 |
| Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts GF Kocsis, J Pipis, V Fekete, A Kovács-Simon, L Odendaal, E Molnar, ... American Journal of Physiology-Heart and Circulatory Physiology 294 (5 …, 2008 | 90 | 2008 |
| Lipid droplet and milk lipid globule membrane associated placental protein 17b (PP17b) is involved in apoptotic and differentiation processes of human epithelial cervical … NG Than, B Sumegi, S Bellyei, T Berki, G Szekeres, T Janaky, A Szigeti, ... European journal of biochemistry 270 (6), 1176-1188, 2003 | 84 | 2003 |
| Highly potent analogues of luteinizing hormone-releasing hormone containing D-phenylalanine nitrogen mustard in position 6. S Bajusz, T Janaky, VJ Csernus, L Bokser, M Fekete, G Srkalovic, ... Proceedings of the National Academy of Sciences 86 (16), 6318-6322, 1989 | 83 | 1989 |
| A mouse model of anxiety molecularly characterized by altered protein networks in the brain proteome ÉM Szegő, T Janáky, Z Szabó, A Csorba, H Kompagne, G Müller, G Lévay, ... European Neuropsychopharmacology 20 (2), 96-111, 2010 | 82 | 2010 |
| The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol Z Kariv-Inbal, S Yacobson, R Berkecz, M Peter, T Janaky, D Lütjohann, ... Journal of Alzheimer's Disease 28 (3), 667-683, 2012 | 80 | 2012 |
| ABCG2 (breast cancer resistance protein/mitoxantrone resistance-associated protein) ATPase assay: a useful tool to detect drug-transporter interactions H Glavinas, E Kis, A Pal, R Kovacs, M Jani, E Vagi, E Molnar, S Bansaghi, ... Drug Metabolism and Disposition 35 (9), 1533-1542, 2007 | 80 | 2007 |
| Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition H Koivisto, MO Grimm, TL Rothhaar, R Berkecz, D Lütjohann, ... The Journal of nutritional biochemistry 25 (2), 157-169, 2014 | 70 | 2014 |
| Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study H Nemeth, H Robotka, Z Kis, É Rózsa, T Janáky, C Somlai, M Marosi, ... Neuropharmacology 47 (6), 916-925, 2004 | 63 | 2004 |
| Molecular mechanism of the short-term cardiotoxicity caused by 2′, 3′-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions G Skuta, GM Fischer, T Janaky, Z Kele, P Szabo, J Tozser, B Sumegi Biochemical pharmacology 58 (12), 1915-1925, 1999 | 62 | 1999 |
Laszlo ProkaiProfessor of Pharmacology & Neuroscience and the Robert A. Welch Chair in Biochemistry, UNT Health Science Center at Fort WorthVerified email at unthsc.edu
